Member access

4-Traders Homepage  >  Shares  >  Nasdaq  >  Auxilium Pharmaceuticals, Inc.    AUXL   US05334D1072

 SummaryQuotesChart AnalysisNewsAnalysisCalendarCompanyFinancialsConsensusRevisions 
Company
Auxilium Pharmaceuticals, Inc. is a specialty biopharmaceutical company.It focuses on developing and marketing products to predominantly specialist audiences, such as urologists, endocrinologists, certain targeted primary care physicians, hand surgeons, subsets of orthopedic, general, and plastic... 
Sector
Pharmaceuticals
Calendar
02/18Earnings Release
More about the company
Surperformance© ratings of Auxilium Pharmaceuticals,
Trading Rating : - Investor Rating :
More Ratings
Chart AUXILIUM PHARMACEUTICALS,
Duration : Period :
Auxilium Pharmaceuticals,  Technical Analysis Chart | AUXL | US05334D1072 | 4-Traders
Full-screen chart
Financials ($)
Sales 2014 398 M
EBIT 2014 15,6 M
Net income 2014 -163 M
Debt 2014 479 M
Yield 2014 -
Sales 2015 501 M
EBIT 2015 118 M
Net income 2015 71,5 M
Debt 2015 364 M
Yield 2015 -
PER 2014 -
PER 2015 26,05
EV / Sales 2014 5,84x
EV / Sales 2015 4,41x
Capitalization 1 846 M
More Financials
Latest news on AUXILIUM PHARMACEUTICALS,
01/30 AUXILIUM PHARMACEUTICALS : Endo completes $2.6bn acquisition of Auxilium
01/29 AUXILIUM PHARMACEUTICALS : Entry into a Material Definitive Agreement, Terminati..
01/27 AUXILIUM PHARMACEUTICALS : Submission of Matters to a Vote of Security Holders, ..
01/27 AUXILIUM PHARMACEUTICALS : Announces Results from Special Meeting of Stockholder..
01/21DJEndo International to Join S&P 500 as Boston Beer Moves Up to MidCap List
01/21 AUXILIUM PHARMACEUTICALS : Other Events (form 8-K)
01/16 AUXILIUM PHARMACEUTICALS : Other Events (form 8-K)
2014 AUXILIUM PHARMACEUTICALS : Regulation FD Disclosure, Financial Statements and Ex..
More news
Sector news Biopharmaceuticals
01/30 SANOFI : 72 HOUR DEADLINE ALERT: Approximately 72 Hours Remain; Former Louisiana..
01/30 ABBVIE : breakup with Shire torpedoes 4th quarter, 2014 results
01/30 ASTRAZENECA : announces collaborations to use CRISPR technology for genome editi..
Plus d'actualités du secteur Biopharmaceuticals


Comments 
Advertisement
Technical analysis trends
Short TermMid-TermLong Term
TrendsBearishBearishBearish
Technical analysis
Income Statement Evolution
More Financials
Dynamic quotes  
ON
| OFF